Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons

Journal of Nuclear Medicine

Volumn 40, Issue 4, 1999, Pages 660-666

  Dresel, Stefan H J ^a   Kung, Mei Ping ^a   Huang, Xiao Feng ^a   Plössl, Karl ^a   Hou, Catherine ^a   Meegalla, Sanath K ^a   Patselas, Gregory ^a   Mu, Mu ^a   Saffer, Janet R ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dopamine D2 D3 receptors; Dopamine transporters; Dual isotope studies; SPECT imaging

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BINDING SITE; DOPAMINE BRAIN LEVEL; FEMALE; LIGAND BINDING; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BENZAMIDES; BENZOFURANS; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PAPIO; PYRROLIDINES; RACLOPRIDE; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE; SALICYLAMIDES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0032962082     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reith MEA, ed. Neurotransmitter Transporters: Structure, Function, and Regulation. Totowa, NJ: Humana Press; 1997:405.
2. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993;16:73-93.
3. 11C]-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol. 1993;34:423-431.
4. Mozley PD, Stubbs JB, Kim H-J, et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl. Med. 1996;37:151-159.
5. 123I]IPT and single-photon emission tomography. Eur J Nucl Med. 1997;24:415-421.
6. Fischman AJ, Bonab AA, Babich JW, et al. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse. 1998;29:128-141.
7. Hom RK, Katzenellenbogen JA. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl Med Bio. 1997;24:485-498.
8. Madras BK, Jones AG, Mahmood A, et al. Technepine: a high affinity technetium-99m probe to label the dopamine transporter in brain by SPECT imaging. Synapse. 1996;22:239-246.
9. Meltzer PC, Blundell P, Jones AG, et al. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. J Med Chem. 1997;40: 1835-1844.
10. Kung HF, Kim H-J, Kung M-P, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med. 1996;23:1527-1530.
11. Meegalla SK, Plössl K, Kung M-P, et al. First example of a Tc-99m complex as a dopamine transporter imaging agent. J Am Chem Soc. 1995;117:11037-11038.
12. Meegalla SK, Plössl K, Kung M-P, et al. Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J Med Chem. 1997;40: 9-17.
13. 99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med. 1997; 24:372-380.
14. 123I]IBZM SPECT to differentiate idiopathic from other Parkinson syndromes [abstract]. J Nucl Med. 1992;33:917-918.
15. 2-receptor binding with iodine-123-IBF SPECT in healthy subjects. J Nucl Med. 1997;38:31-37.
16. 2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med. 1990;31: 573-579.
17. 2 dopamine receptor blockade hypothesis of schizophrenia. Lancet. 1992;340:199-202.
18. Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in risperidone-treated schizophrenic patients. J Nucl Med. 1998;39:1138-1142.
19. O'Leary DS, Madsen MT, Hurtig R, et al. Dual isotope brain SPECT imaging for monitoring cognitive activation: initial studies in humans. Nucl Med Commun. 1993;14:397-404.
20. Devous MD Sr, Payne JK, Lowe JL. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT. J Nucl Med. 1992;33:1919-1924.
21. Devous MD Sr, Lowe JL, Payne JK. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: validation by phantom studies. J Nucl Med. 1992;33:2030-2035.
22. 2 dopamine receptor imaging agent. J Nucl Med. 1991;32:339-342.
23. 2 dopamine receptor imaging agents. J Med Chem. 1990;33:171-178.
24. 99mTc]TRODAT-1 to the central dopamine transporters in rats. Eur J Nucl Med. 1998;25:31-39.
25. Mozley PD, Kim HJ, Gur RC, et al. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med. 1996;37:1965-1970.
26. Asenbaum S, Brücke T, Pirker W, et al. Imaging of dopamine transporters with iodine-123-β-CIT and SPECT in Parkinson's disease. J Nucl Med. 1997;38:1-6.
27. Mozley PD, Stubbs JB, Plössl K, et al. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. J Nucl Med. 1998;39:2069-2076.
28. 2 receptor blockade by typical and atypical neuroleptics [letter]. Lancet. 1992;339:497.
29. Sedvall G, Farde L, Hall H, et al. Utilization of radioligands in schizophrenia research. Clin Neurosci. 1995;3:112-121.
30. 2 dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Biol Psychiatry. 1994;36:627-629.
31. 123I IBZM single photon emission tomography (SPET) study. Psychopharmacology. 1997; 130:152-158.
32. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986;20:296-303.
33. 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl Med Commun. 1991;12:699-707.
34. Schwarz J, Tatsch K, Vogl T, et al. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia. Mov Disord. 1992;7:58-61.
35. 99mTc]TRODAT-1: a novel compound for imaging the dopamine transporter [abstract]. J Nucl Med. 1997;38:61P.
36. 123I: evaluation of optimal window setting with myocardial phantom. Kaku Igaku. 1995;32:183-190.
37. Madsen MT, O'Leary DS, Andreasen NC, Kirchner PT. Dual isotope brain SPECT imaging for monitoring cognitive activation: physical considerations. Nucl Med Commun. 1993;14:391-396.
38. Kilbourn MR. Shades of grey: radiopharmaceutical chemistry in the 1990s and beyond. Int J Radiat Appl Inst Part B: Nucl Med Biol. 1992;19:603-606.